Buscopan for the treatment of pain after laparoscopic sterilisation.
We investigated the effect of Buscopan 20 mg, given at the end of surgery, on analgesic requirements in 44 ASA I and II patients presenting as day cases for laparoscopic sterilisation using Filshie clips. Patients were randomly allocated to receive either intravenous Buscopan 20 mg or saline placebo at the end of surgery. There was no significant difference in pain scores, analgesic requirements or the incidence of nausea and vomiting between the two groups. We conclude that intravenous Buscopan 20 mg was not effective for pain relief following laparoscopic sterilisation.
Habib
A
A
University Department of Anaesthesia and Pain Management, Leicester Royal Infirmary, Leicester LE1 5WW, UK.
Sharpe
P
P
Anderson
S
S
Francis
S
S
Davidson
A C
AC
Smith
G
G
D000328:Adult; D002086:Butylscopolammonium Bromide / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D010535:Laparoscopy; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D010147:Pain Measurement; D010149:Postoperative Pain / Q000517:prevention & control*; D013246:Sterilization, Tubal / Q000295:instrumentation / Q000379:methods*; D016896:Treatment Outcome
D018727:Muscarinic Antagonists; D002086:Butylscopolammonium Bromide